Effect of β-cyclodextrin complexation on physicochemical properties of zaleplon

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 62, Issue 1-2, 2008, Pages 43-50

  Doiphode, Dipali ^a   Gaikwad, Shubhangee ^a   Pore, Yogesh ^a   Kuchekar, Bhanudas ^a   Late, Sameer ^b  

^a Government College of Pharmacy   (India)

^b MERCER UNIVERSITY   (United States)

Author keywords

cyclodextrin; Dissolution rate; Inclusion complex; Phase solubility; Zaleplon

Indexed keywords

EID: 51649119602     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-008-9435-3     Document Type: Article

References (26)

1. Dooley, M., Plosker, G.: Zaleplon a review of its use in the treatment of insomnia. Drugs 60, 413-445 (2000)
2. Hurst, M., Noble, S.: Zaleplon. CNS Drugs 11, 387-392 (1999)
3. A receptors different from zolpidem, zopiclone and benzodiazepines. Neurosci. Res. Commun. 25, 139-148 (1999)
4. Vandelli, M.A., Salvioli, G., Mucci, A., Panini, R., Malmusi, L., Forni, F.: 2-Hydroxypropyl-β-cyclodextrin complexation with ursodeoxycholic acid. Int. J. Pharm. 118, 77-83 (1995)
5. Fernandes, C.M., Vieira, M.T., Viega, F.J.B.: Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Eur. J. Pharm. Sci. 15, 79-88 (2002)
6. Archontaki, H.A., Vertzoni, M.V., Athanassiou-Malaki M.H.: Study on the inclusion complexes of bromazepam with α- and β-hydroxypropyl- cyclodextrins. J. Pharm. Biomed. Anal. 28, 761-769 (2002)
7. MunozPen, A., Ndou, T.T., Zung, J.B., Greene, K.L., Live, D.H., Warner, I.M.: Alcohol size as a factor in the ternary complexes formed with pyrene and β-cyclodextrin. J. Am. Chem. Soc. 113, 1572-1577 (1991)
8. Reddy, M.N., Rehana, T., Ramakrishna, S., Chowdary, K.P.R., Diwan, P.V.: β-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies. AAPS PharmSci. 6, E7 (2004)
9. Figueiras, A., Ribeiro, L., Vieira, M.T., Veiga, F.: Preparation and physicochemical characterization of omeprazole:methyl-beta-cyclodextrin inclusion complex in solid state. J. Inclusion Phenom. Macrocycl. Chem. 57, 173-177 (2007)
10. Peeters, J., Neeskens, P., Brewster, M.E.: Development of a formulation of Pirodavir using 2-hydroxypropyl-b-cyclodextrin. J. Inclusion Phenom. Macrocycl. Chem. 57, 137-139 (2007)
11. Sanghavi, N.M., Mayekar, R., Fruitwala, M.: Inclusion complexes of terfenadine-cyclodextrins. Drug Dev. Ind. Pharm. 21, 375-381 (1995)
12. Bruce, J.A.: Intestinal permeation enhancers- mini-review. J. Pharm. Sci. 89, 429-441 (2000)
13. Mar, M., Thorsteinn, L., Gisli, M.: Cyclodextrins as permeation enhancers: some theoretical evaluation and in-vitro testing. J. Control. Release 59, 107-118 (1999)
14. Gian, C., Paolo, C., Simone, L.: Skin permeation study of dehydroepiandrosterone (DHEA) compared with its α-cyclodextrin complex form. J. Pharm. Sci. 91, 2399-2405 (2002)
15. Loftsson T., Bodor N.: The effect of cyclodextrins on percutaneous transport of drugs. In: Smith, E.W., Maibach, H.I. (eds.) Percutaneous Penetration Enhancers, pp. 335-342. CRC Press, Boca Raton (1995)
16. Brun, H., Paul, M., Razzouq, N., Binhas, M., Gibaud, S., Astier, A.: Cyclodextrin inclusion complexes of the central analgesic drug nefopam. Drug Dev. Ind. Pharm. 32, 1123-1134 (2006)
17. Longxiao, L., Suyan, Z.: Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. J. Pharm. Biomed. Anal. 40, 122-127 (2006)
18. Masson, M., Loftsson, T., Masson, G., Stefanson, E.: Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J. Control. Release 59, 107-118 (1999)
19. Higuchi, T., Connors, K.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117-212 (1965)
20. X.Wen, Tan, F., Jing, Z., Liu, Z.: Preparation and study the 1:2 inclusion complex of carvedilol with β-cyclodextrin. J. Pharm. Biomed. Anal. 34, 517-523 (2004)
21. Mielcarek, J.: Studies on Inclusion Complexes of Felodipine with β-Cyclodextrin. J. Inclusion Phenom. Mol. 30, 243-252 (1998)
22. Cvetkovskii, J., Bettini, R., Tasic, Lj., Stupar, M., Casini, I., Rossi, A., Giordano, F.: Thermal properties of binary mixtures of beta-cyclodextrin with carbamazepine polymorphs. J. Therm. Anal. Calorim. 68, 669-678 (2002)
23. Ryan, J.A.: Compressed pellet x-ray diffraction monitoring for optimisation of crystallinity in lyophilised solids: imipenem: cilastatin sodium case. J. Pharm. Sci. 75, 805-807 (1986)
24. Uekama, K., Hirayama, F.: Improvement of drug properties by cyclodextrin. In: Wermuth, C.G. (ed) The Practice of Medicinal Chemistry, pp. 793-825. Academic Press, London (1996)
25. Szetli, J.: Medicinal applications of cyclodextrins. Med. Res. Rev. 14, 353-386 (1994)
26. Trapani, G., Latrofa, A., Franco, M.: Complexation of zolpiden with 2-hydroxypropyl-b-, methyl-b-, and 2-hydroxypropyl-g-cyclodextrin: Effect on aqueous solubility, dissolution rate and ataxic activity in rat. J. Pharm. Sci. 89, 1443-1451 (2000)